Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Study Evaluating the Efficacy and Safety of the iCan i3 Continuous Glucose Monitoring System in Post-Bariatric Patients With Late Dumping Syndrome

NCT07440706 is registered in ClinicalTrials.gov with Kaiser Clinic and Hospital as lead sponsor.

NCT NCT07440706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07440706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Study Evaluating the Efficacy and Safety of the iCan i3 Continuous Glucose Monitoring System in Post-Bariatric Patients With Late Dumping Syndrome
Lead sponsor
Kaiser Clinic and Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 15, 2025
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dumping syndrome, post-bariatric hypoglycemia